TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21863477

Group type: EXPERIMENTAL
Intervention: Polymeric nanoparticles containing celecoxib dosed orally in aqueous suspensions
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial capsules of celecoxib
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nanoparticle suspensions
Number of subjects: 0
Study: 20587484

Group type: EXPERIMENTAL
Intervention: freeze-dried 5% IVIg (Gammagard S/D)
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: liquid 10% IVIg (Kiovig)
Number of subjects: 27

Group type: COMPARATOR
Intervention: Gammagard S/D
Number of subjects: 27
Study: 17980251

Group type: EXPERIMENTAL
Intervention: AZD6140 90 mg twice a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZD6140 180 mg twice a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg once a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: AZD6140 (both doses) in clopidogrel pretreated patients
Number of subjects: 0
Study: 15793737

Group type: EXPERIMENTAL
Intervention: Continuing antibiotics
Number of subjects: 85

Group type: COMPARATOR
Intervention: Discontinuing antibiotics
Number of subjects: 85
Study: 12377396

Group type: EXPERIMENTAL
Intervention: Acamprosate (2 g/d)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Naltrexone (50 mg/d)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Acamprosate and Naltrexone (combined)
Number of subjects: 24
Study: 9811045

Group type: EXPERIMENTAL
Intervention: IR501 90 microg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: IR501 300 microg
Number of subjects: 99

Group type: COMPARATOR
Intervention: Control (IFA alone)
Number of subjects: 99
Study: 8580920

Group type: EXPERIMENTAL
Intervention: Nocturnal eating in binge eating disorder patients
Number of subjects: 79

Group type: COMPARATOR
Intervention: Nocturnal eating in matched-weight controls
Number of subjects: 79
Study: 2502013

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 64

Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Doxycycline and Amoxicillin
Number of subjects: 64
Study: 899774

Group type: EXPERIMENTAL
Intervention: Diazepam rectally as a solution (0.7 mg/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Diazepam rectally by suppository (5 mg)
Number of subjects: 20
Study: 31283865

Group type: EXPERIMENTAL
Intervention: Quetiapine extended-release (QUEXR300), 300 mg/d
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olanzapine (OLA), 5-20 mg/d
Number of subjects: 0
Study: 28801393

Group type: EXPERIMENTAL
Intervention: mWellcare system (mHealth intervention)
Number of subjects: 3702

Group type: COMPARATOR
Intervention: Enhanced usual care (control)
Number of subjects: 3702
Study: 25444953

Group type: EXPERIMENTAL
Intervention: Top-down approach using (99m)technetium dimercaptosuccinic acid renal scintigraphy
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bottom-up approach using voiding cystourethrography
Number of subjects: 120

Group type: COMPARATOR
Intervention: Repeat voiding cystourethrography
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Top-down approach
Number of subjects: 120

Group type: COMPARATOR
Intervention: Bottom-up approach
Number of subjects: 120
Study: 23784548

Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride 0.06 mg/kg
Number of subjects: 183

Group type: EXPERIMENTAL
Intervention: Landiolol hydrochloride 0.125 mg/kg
Number of subjects: 183

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 183
Study: 21700683

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg twice a week (biw)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Etanercept 50 mg once a week (qw)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg biw and qw
Number of subjects: 108
Study: 19935987

Group type: EXPERIMENTAL
Intervention: Biofeedback plus relaxation techniques
Number of subjects: 64

Group type: COMPARATOR
Intervention: Relaxation techniques alone
Number of subjects: 64
Study: 17173662

Group type: EXPERIMENTAL
Intervention: 1 kcal/minute nutrient infusion
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: 2 kcal/minute nutrient infusion
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Fasting PYY concentration
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Fasting and nutrient-stimulated plasma CCK concentrations
Number of subjects: 19
Study: 12634025

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI) - three individual diet counseling sessions by a public health nurse, using the Food for Heart Program, referral to a nutritionist if lipid goals not achieved, reinforcement phone call and newsletters.
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Special Intervention (SI)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Minimal Intervention (MI)
Number of subjects: 216
Study: 11000915

Group type: EXPERIMENTAL
Intervention: Alcohol dependence
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Nicotine dependence
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: Caffeine dependence
Number of subjects: 196
Study: 9176746

Group type: EXPERIMENTAL
Intervention: Netilmicin plus imipenem-cilastatin (Net + Imi)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Netilmicin plus ceftazidime (Net + Cef)
Number of subjects: 66
Study: 1584658

Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nonnutritive sucking plus rocking
Number of subjects: 20

Group type: COMPARATOR
Intervention: Stroking intervention
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 20
Study: 2580383

Group type: EXPERIMENTAL
Intervention: ERU-capsules
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 29871370

Group type: EXPERIMENTAL
Intervention: Percutaneous balloon kyphoplasty (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: PVP with dilated balloon placement (Group B)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both interventions (Group A and Group B)
Number of subjects: 80
Study: 27530663

Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone 500 mg given 2 hours or more prior to antivenom therapy (Group A)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Intravenous hydrocortisone at the time of antivenom therapy (Group B)
Number of subjects: 236
Study: 23957945

Group type: EXPERIMENTAL
Intervention: Docetaxel every 3 weeks (D3) with prednisone
Number of subjects: 1006

Group type: COMPARATOR
Intervention: Mitoxantrone every 3 weeks (M3) with prednisone
Number of subjects: 1006
Study: 22169130

Group type: EXPERIMENTAL
Intervention: Baseline heart rate (HR) increment of 10 beats/min
Number of subjects: 15193

Group type: COMPARATOR
Intervention: Highest HR quintile
Number of subjects: 15193

Group type: COMPARATOR
Intervention: Top baseline HR quintile
Number of subjects: 15193

Group type: COMPARATOR
Intervention: Highest in-trial HR quintile
Number of subjects: 15193

Group type: COMPARATOR
Intervention: Highest in-trial HR group
Number of subjects: 15193
Study: 19884643

Group type: EXPERIMENTAL
Intervention: Bortezomib (1 mg/m² x 4) and melphalan (200 mg/m²) as conditioning regimen (Bor‐HDM)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Bortezomib (Bor‐HDM)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Bor‐HDM
Number of subjects: 54

Group type: COMPARATOR
Intervention: HDM alone (control group)
Number of subjects: 54
Study: 18540870

Group type: EXPERIMENTAL
Intervention: Naratriptan 2.5 mg
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Sumatriptan 100 mg
Number of subjects: 3

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3
Study: 15677511

Group type: EXPERIMENTAL
Intervention: Diabetic retinopathy severity assessment using the ETDRS severity scale
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Renal anatomical endpoints assessment
Number of subjects: 285

Group type: EXPERIMENTAL
Intervention: Correlation with AER, blood pressure, serum creatinine, and GFR
Number of subjects: 285
Study: 12151873

Group type: EXPERIMENTAL
Intervention: Candesartan (AT1-antagonist)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 10214783

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP; 500 mg twice daily for 10 days, placebo for 4 days)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Clarithromycin (CLARI; 500 mg twice daily for 14 days)
Number of subjects: 560

Group type: COMPARATOR
Intervention: Clarithromycin (CLARI)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP)
Number of subjects: 560

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP) and Clarithromycin (CLARI)
Number of subjects: 560
Study: 7878711

Group type: EXPERIMENTAL
Intervention: Vapor-heated human factor VII concentrate
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Vapor-heated human factor IX complex
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Combined vapor-heated factor VII concentrate and factor IX complex
Number of subjects: 25

Group type: COMPARATOR
Intervention: Vapor-heated factor VII concentrate alone
Number of subjects: 25
Study: 2170309

Group type: COMPARATOR
Intervention: Radiotherapy alone (arm I)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radiotherapy plus cDDP given once a week (arm II)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Radiotherapy combined with daily cDDP (arm III)
Number of subjects: 100
Study: 6104933

Group type: EXPERIMENTAL
Intervention: Continuous application of Diazepam, Flunitrazepam, and Benzoctamin in 500 ml physiological NaCl-Solution
Number of subjects: 0

Group type: COMPARATOR
Intervention: Bolus injection of sedatives (implied control)
Number of subjects: 0
Study: 31775854

Group type: EXPERIMENTAL
Intervention: Volatile anesthesia (sevoflurane or desflurane) during surgery
Number of subjects: 500

Group type: COMPARATOR
Intervention: Propofol-based total intravenous anesthesia (TIVA) during surgery
Number of subjects: 500
Study: 29925363

Group type: EXPERIMENTAL
Intervention: State-owned media
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Health and academic experts and organizations
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Citizen journalists and unofficial social groups
Number of subjects: 902

Group type: EXPERIMENTAL
Intervention: Traditional media posts
Number of subjects: 902
Study: 24476774

Group type: EXPERIMENTAL
Intervention: Imagery (experimental PU condition)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Preparatory arousal (experimental PU condition)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Attention placebo (control condition)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Distraction (control condition)
Number of subjects: 16
Study: 26208985

Group type: EXPERIMENTAL
Intervention: Pioglitazone added to risperidone
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study: 23757456

Group type: EXPERIMENTAL
Intervention: 10% CPP‐AC P + 0.2% NaF
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 10% CPP‐AC P
Number of subjects: 45

Group type: COMPARATOR
Intervention: 0.5% NaF mouthrinse
Number of subjects: 45
Study: 21385086

Group type: EXPERIMENTAL
Intervention: Osteopathic manipulative treatment (OMT) - five 50-minute sessions over a 10-week period
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no OMT, sham treatment, or physical therapy)
Number of subjects: 42
Study: 19177862

Group type: EXPERIMENTAL
Intervention: 0.125% bupivacaine plus 1 microg mL(‐1) of sufentanil in continuous infusion at a rate of 7 mL h(‐1)
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: 0.0625% bupivacaine plus 1 microg mL(‐1) of sufentanil in continuous infusion at a rate of 7 mL h(‐1)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Rescue analgesia with intravenous ketoprofen and morphine
Number of subjects: 43
Study: 16995546

Group type: EXPERIMENTAL
Intervention: Wavefront-guided LASIK
Number of subjects: 92

Group type: COMPARATOR
Intervention: Conventional LASIK
Number of subjects: 92
Study: 14655325

Group type: EXPERIMENTAL
Intervention: Inside Case Management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Outside Case Management
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telecommunications Case Management
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no additional case management)
Number of subjects: 0
Study: 10709796

Group type: EXPERIMENTAL
Intervention: Dietary intervention program
Number of subjects: 1795
Study: 9106790

Group type: EXPERIMENTAL
Intervention: LCT emulsion
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: MCT/LCT emulsion
Number of subjects: 10

Group type: COMPARATOR
Intervention: Fat-free TPN
Number of subjects: 10
Study: 8509823

Group type: EXPERIMENTAL
Intervention: Intra-arterial mannitol infusion (50 ml of 20% mannitol at 50 ml/min) prior to ACNU and CDDP (100 mg/body at 20 mg/min)
Number of subjects: 98

Group type: COMPARATOR
Intervention: ACNU and CDDP (100 mg/body at 20 mg/min) without mannitol infusion
Number of subjects: 98
Study: 2862516

Group type: EXPERIMENTAL
Intervention: Interferon and acyclovir combination therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon alone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Acyclovir alone
Number of subjects: 0
Study: 31298466

Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation during VLCKD
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Placebo during VLCKD and synbiotics during LCD
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 33
Study: 29362795

Group type: EXPERIMENTAL
Intervention: Massed therapy (10 sessions over 2 weeks)
Number of subjects: 370

Group type: COMPARATOR
Intervention: Minimal-contact control (MCC; telephone calls from therapists, once weekly for 4 weeks)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Spaced therapy (10 sessions over 8 weeks)
Number of subjects: 370

Group type: EXPERIMENTAL
Intervention: Present-centered therapy (PCT; 10 sessions over 8 weeks)
Number of subjects: 370
Study: 26815734

Group type: EXPERIMENTAL
Intervention: Insole with metatarsal and medial arch supports
Number of subjects: 80

Group type: COMPARATOR
Intervention: Flat insole
Number of subjects: 80
Study: 25594166

Group type: EXPERIMENTAL
Intervention: α-lipoic acid (0.3 g/d)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: EPA (1.3 g/d)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: EPA+α-lipoic acid (1.3 g/d + 0.3 g/d)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 97
Study: 22406434

Group type: EXPERIMENTAL
Intervention: Sodium nitrate (0.15 mmol/kg or 12.7 mg/kg) in 150 ml water
Number of subjects: 0

Group type: COMPARATOR
Intervention: Water alone (control)
Number of subjects: 0
Study: 20363308

Group type: EXPERIMENTAL
Intervention: Ondansetron Rapidfilm
Number of subjects: 24

Group type: COMPARATOR
Intervention: Zofran Zydis Lingual ODT
Number of subjects: 24
Study: 18592783

Group type: EXPERIMENTAL
Intervention: Weekly nedaplatin (30 mg/mm2/time, once a week, total 150 mg/mm2/5 weeks) combined with radiation therapy (50 Gy-52 Gy/25-27 fractions with central shielding after 30-32 Gy and high-dose rate intracavitary irradiation 24-30 Gy/4-6 fractions to point A)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Weekly nedaplatin combined with radiation therapy
Number of subjects: 45
Study: 15977094

Group type: EXPERIMENTAL
Intervention: Bupivacaine-fentanyl (BF)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Bupivacaine-morphine (BM)
Number of subjects: 60
Study: 12646507

Group type: EXPERIMENTAL
Intervention: High fiber (13.5 g/day)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Low fiber (2.0 g/day)
Number of subjects: 68
Study: 10332461

Group type: EXPERIMENTAL
Intervention: Sphincterotomy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Sphincteric stent placement
Number of subjects: 57
Study: 7788131

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 4

Group type: COMPARATOR
Intervention: Lithium
Number of subjects: 4
Study: 3391002

Group type: EXPERIMENTAL
Intervention: Verapamil, 120 mg every 8 hours for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Diltiazem, 90 mg every 8 hours for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Nifedipine, 20 mg every 8 hours for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (theophylline alone, 5 mg/kg)
Number of subjects: 12
Study: 1054222

Group type: EXPERIMENTAL
Intervention: Laminar air flow room reverse isolation with oral nonabsorbable antibiotics (LAF plus A)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Routine hospital ward care with antibiotics (W plus A)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Ward care alone (W)
Number of subjects: 64
Study: 31752905

Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 26
Study: 28652968

Group type: EXPERIMENTAL
Intervention: Acoustic CR neuromodulation
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Noisy CR-like stimulation
Number of subjects: 18

Group type: COMPARATOR
Intervention: Low frequency range (LFR) stimulation
Number of subjects: 18
Study: 26902007

Group type: EXPERIMENTAL
Intervention: Postoperative infiltration of local anesthesia at the wound site
Number of subjects: 58

Group type: COMPARATOR
Intervention: No local anesthesia
Number of subjects: 58
Study: 23242843

Group type: EXPERIMENTAL
Intervention: Propofol TCI at 5 μg/mL for 2 min followed by 3 μg/mL
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sevoflurane 5% at inhaled concentration
Number of subjects: 50
Study: 21526413

Group type: EXPERIMENTAL
Intervention: Pharmacist-initiated medication use review
Number of subjects: 400
Study: 18073485

Group type: EXPERIMENTAL
Intervention: Placental removal at 20 min
Number of subjects: 1607

Group type: COMPARATOR
Intervention: Placental removal at 30 min
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Maternal age > or =35 years
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Duration of second stage of labor >2 h
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Chorioamnionitis
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Nulliparity
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Overdistended uterus
Number of subjects: 1607

Group type: EXPERIMENTAL
Intervention: Third stage of labor >10 min
Number of subjects: 1607
Study: 21198365

Group type: EXPERIMENTAL
Intervention: Cell-phone conversation or text-message task during study
Number of subjects: 0

Group type: COMPARATOR
Intervention: No distractions during study
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cell-phone or text-message distractions present
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cell-phone or text-message distractions absent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All distraction conditions
Number of subjects: 0
Study: 17877128

Group type: EXPERIMENTAL
Intervention: Estradiol therapy (ET)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Premenopausal women (group M)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Postmenopausal women (group K)
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: DHEA-S concentration in group K
Number of subjects: 120

Group type: COMPARATOR
Intervention: DHEA-S concentration in group M
Number of subjects: 120
Study: 11809183

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin
Number of subjects: 122

Group type: COMPARATOR
Intervention: High-dose methylprednisolone
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin with oral prednisone
Number of subjects: 122

Group type: COMPARATOR
Intervention: High-dose methylprednisolone with oral prednisone
Number of subjects: 122
Study: 9466467

Group type: EXPERIMENTAL
Intervention: Immunomodulatory agents
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Preclinical trials using models of sepsis and shock
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Clinical trials of agents based on clinically flawed models
Number of subjects: 0
Study: 8056888

Group type: EXPERIMENTAL
Intervention: 10% benzoyl peroxide gel applied once a day for 7 days before surgery
Number of subjects: 673

Group type: COMPARATOR
Intervention: No antibacterial prophylaxis
Number of subjects: 673
Study: 2972270

Group type: EXPERIMENTAL
Intervention: Amantadine hydrochloride therapy
Number of subjects: 10
Study: 15830485

Group type: EXPERIMENTAL
Intervention: Cephalothin (1 g intravenous dose) over 120, 30, and 3 min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Cefoxitin (1 g intravenous dose) over 120, 30, and 3 min
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Probenecid (1 g intravenous infusion) prior to cephalothin
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Probenecid (1 g intravenous infusion) prior to cefoxitin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cephalothin
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 12
Study: 27575015

Group type: EXPERIMENTAL
Intervention: High-Intensity Treadmill Training (HITT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Low-Intensity Treadmill Training (LITT)
Number of subjects: 16
Study: 27249461

Group type: EXPERIMENTAL
Intervention: Fractional 1064-nm QSNY
Number of subjects: 13

Group type: COMPARATOR
Intervention: Conventional 1064-nm QSNY
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both groups (Fractional and Conventional 1064-nm QSNY)
Number of subjects: 13
Study: 24597283

Group type: EXPERIMENTAL
Intervention: Luteal support with progesterone
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no luteal support)
Number of subjects: 110
Study: 21885068

Group type: EXPERIMENTAL
Intervention: Gentamicin-collagen sponge
Number of subjects: 720

Group type: COMPARATOR
Intervention: Control (collagen sponge)
Number of subjects: 720
Study: 20146965

Group type: EXPERIMENTAL
Intervention: Educational leaflet (counselled group)
Number of subjects: 211

Group type: COMPARATOR
Intervention: Non-counselled group (control)
Number of subjects: 211
Study: 18335515

Group type: EXPERIMENTAL
Intervention: MYO-029 at 1 mg/kg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: MYO-029 at 3 mg/kg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: MYO-029 at 10 mg/kg
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: MYO-029 at 30 mg/kg
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: MYO-029 (all doses)
Number of subjects: 116
Study: 15709851

Group type: EXPERIMENTAL
Intervention: Divorce mediation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonacceptance (mothers)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonacceptance (fathers)
Number of subjects: 0